NSCLC Adjuvant Targeted Therapy
Sort by:
GRACE
Adding to Targeted Therapy in NSCLC: Current Statistics and Biology
FEATURING
Puneeth Iyengar
- 87 views
- February 13, 2024
GRACE
Local Therapy for Oligometastatic NSCLC Patients After Frontline Therapy
FEATURING
Puneeth Iyengar
- 45 views
- February 13, 2024
GRACE
Key Points From the ADAURA Trial: Osimertinib in NSCLC
FEATURING
Joshua Reuss
- 115 views
- February 13, 2024
Insights from 2023 ESMO Asia Annual Meeting
Oncogene-Driven NSCLC: RET, NTRK, and ROS1
FEATURING
Junko Tanizaki
- 428 views
- February 7, 2024
Yale Cancer Center
Navigating the Terrain: Recent Treatment Strategies for EGFRm Advanced NSCLC
FEATURING
Amin Nassar
- 493 views
- February 7, 2024
- 2
Dana-Farber Cancer Institute
Updates in KRAS G12C Mutant NSCLC: Demographics, Clinical Features, Genomics, and Treatment
FEATURING
Biagio Ricciuti
- 242 views
- January 8, 2024
- 1
Insights from 2023 ESMO Asia Annual Meeting
ESMO Asia 2023 Insights: "EGFR TKIs in NSCLC - Which One, How Long, When, and Who"
FEATURING
Masahiro Tsuboi
- 56 views
- January 3, 2024
- 1
Lorenzo Belluomini
Selpercatinib in Patients With RET Fusion-Positive NSCLC: Where Are We Now?
- 62 views
- December 22, 2023
- 1
Yale Cancer Center
Progress in the Treatment of NSCLC
FEATURING
Roy Herbst
- 510 views
- December 20, 2023
- 3
University of Illinois Cancer Center
KRASG12C Testing in NSCLC
FEATURING
Frank Weinberg
- 278 views
- December 20, 2023
Memorial Sloan Kettering Cancer Center
NSCLC & Targeted Therapy: A Brief Overview and Update in the Metastatic Setting
FEATURING
Michael Hwang
- 1,203 views
- December 13, 2023
- 13
Blanca Ledezma
Practical Guidance for the Management of Adverse Events in Patients With NSCLC Receiving KRASG12C Inhibitors
- 633 views
- November 14, 2023
- 1
2023 Evolution Conference
IO and Targeted Treatment for mNSCLC
FEATURING
Meghan Mooradian
- 469 views
- November 8, 2023
- 2
Yale Cancer Center
Treatment Approach to ROS1 Rearranged NSCLC
FEATURING
Michael Grant
- 528 views
- October 19, 2023
- 2
Total Health
Case-Based Clinical Updates in NSCLC: 63 y/o With RET-Altered Disease
- 208 views
- October 17, 2023
- 1
Insights from 2023 WCLC
WCLC 2023 Insights: "Mechanisms of Resistance to KRAS G12C Inhibitors in NSCLC"
FEATURING
Biagio Ricciuti
- 100 views
- October 9, 2023
- 1
Total Health
ADAURA & KEYNOTE-671 Trials: Early Stage NSCLC Updates - 2023 ASCO® Direct Philadelphia
FEATURING
Jessica Bauman
- 400 views
- September 29, 2023
- 3